$72 Million is the total value of Blackcrane Capital, LLC's 14 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FERG | Sell | FERGUSON PLC | $16,094,000 | +18.3% | 90,780 | -7.2% | 22.34% | +28.9% |
| NICE | Sell | NICE LTD - SPON ADRsponsored adr | $12,641,000 | +6.9% | 41,638 | -0.0% | 17.55% | +16.4% |
| PROF | Buy | PROFOUND MEDICAL CORP | $11,262,000 | -1.7% | 1,001,643 | +27.8% | 15.64% | +7.1% |
| WIX | Buy | WIX.COM LTD | $9,543,000 | -14.9% | 60,478 | +5.7% | 13.25% | -7.2% |
| RCEL | Buy | AVITA THERAPEUTICS INC | $5,449,000 | -29.2% | 454,871 | +4.8% | 7.56% | -22.9% |
| HDB | HDFC BANK LTD-ADRsponsored ads | $4,596,000 | -11.0% | 70,630 | 0.0% | 6.38% | -3.0% | |
| TAK | Buy | TAIWAN SEMICONDUCTOR-SP ADRsponsored ads | $3,746,000 | +18.7% | 31,138 | +10.1% | 5.20% | +29.3% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOG | $2,616,000 | -10.9% | 46,716 | +3.6% | 3.63% | -2.9% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $2,173,000 | -26.1% | 139,552 | +6.5% | 3.02% | -19.5% |
| MSFT | MICROSOFT CORP | $1,623,000 | +19.3% | 4,826 | 0.0% | 2.25% | +29.9% | |
| ARCE | New | ARCO PLATFORM LTD - CLASS A | $875,000 | – | 41,886 | +100.0% | 1.22% | – |
| BABA | Sell | ALIBABA GROUP HOLDING-SP ADRsponsored ads | $718,000 | -37.1% | 6,047 | -21.6% | 1.00% | -31.4% |
| New | VTEX | $689,000 | – | 64,232 | +100.0% | 0.96% | – | |
| CLPT | Exit | CLEARPOINT NEURO INC | $0 | – | -28,817 | -100.0% | -0.65% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -111,608 | -100.0% | -3.15% | – |
| OTEX | Exit | OPEN TEXT CORP | $0 | – | -61,240 | -100.0% | -3.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.